This report studies the global Novel Drug Delivery Systems market status and forecast, categorizes the global Novel Drug Delivery Systems market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms. Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living. The classification of Novel Drug Delivery Systems includes Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein?drug Conjugates, and the proportion of PEGylated Proteins & Polypeptides in 2017 is about 39.60%, and the proportion is in decreasing trend from 2013 to 2017. North America is the largest consumption place, with a consumption market share nearly 49.69% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26.15%. The global Novel Drug Delivery Systems market is valued at 26500 million US$ in 2017 and will reach 31100 million US$ by the end of 2025, growing at a CAGR of 2.0% during 2018-2025. The major manufacturers covered in this report Amgen Teva UCB?(Union Chimique Belge) Roche Celgene Sanofi Merck Johnson & Johnson Takeda Gilead Sciences Pfizer Dr Reddy Samyang Biopharmaceuticals TOLMAR Astellas AMAG?Pharmaceuticals AstraZeneca AbbVie Bausch?Lomb TWi Pharmaceuticals Novartis Aspen Shire Breckenridge Pharmaceuticals Galen Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America Europe China Japan India Southeast Asia Other regions (Central & South America, Middle East & Africa) We can also provide the customized separate regional or country-level reports, for the following regions: North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Rest of Asia-Pacific Europe Germany France UK Italy Spain Russia Rest of Europe Central & South America Brazil Argentina Rest of South America Middle East & Africa Saudi Arabia Turkey Rest of Middle East & Africa On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Liposomes PEGylated Proteins & Polypeptides Polymer Nanoparticle Protein?drug Conjugates Others By Application, the market can be split into Hospitals & Clinic Cancer Treatment Centers Others The study objectives of this report are: To analyze and study the global Novel Drug Delivery Systems capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025); Focuses on the key Novel Drug Delivery Systems manufacturers, to study the capacity, production, value, market share and development plans in future. Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. To define, describe and forecast the market by type, application and region. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends and factors driving or inhibiting the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Novel Drug Delivery Systems are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders Novel Drug Delivery Systems Manufacturers Novel Drug Delivery Systems Distributors/Traders/Wholesalers Novel Drug Delivery Systems Subcomponent Manufacturers Industry Association Downstream Vendors Available Customizations With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report: Regional and country-level analysis of the Novel Drug Delivery Systems market, by end-use. Detailed analysis and profiles of additional market players.
Table of Contents Global Novel Drug Delivery Systems Market Professional Survey Report 2018 1 Industry Overview of Novel Drug Delivery Systems 1.1 Definition and Specifications of Novel Drug Delivery Systems 1.1.1 Definition of Novel Drug Delivery Systems 1.1.2 Specifications of Novel Drug Delivery Systems 1.2 Classification of Novel Drug Delivery Systems 1
